Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers (2011)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00228-011-1003-x
- Subjects: FÁRMACOS (EFEITOS); ÓXIDO NÍTRICO; ESTRESSE OXIDATIVO; HIPERTENSÃO
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2011
- Source:
- Título: European Journal of Clinical Pharmacology
- ISSN: 0031-6970
- Volume/Número/Paginação/Ano: v. 67, n. 4, p. 365-370, 2011
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
SILVA, Pâmela Souza et al. Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. European Journal of Clinical Pharmacology, v. 67, n. 4, p. 365-370, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00228-011-1003-x. Acesso em: 14 mar. 2026. -
APA
Silva, P. S., Fontana, V., Palei, A. C. T., Sertorio, J. T. C., Biagi, C., & Tanus-Santos, J. E. (2011). Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. European Journal of Clinical Pharmacology, 67( 4), 365-370. doi:10.1007/s00228-011-1003-x -
NLM
Silva PS, Fontana V, Palei ACT, Sertorio JTC, Biagi C, Tanus-Santos JE. Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers [Internet]. European Journal of Clinical Pharmacology. 2011 ; 67( 4): 365-370.[citado 2026 mar. 14 ] Available from: https://doi.org/10.1007/s00228-011-1003-x -
Vancouver
Silva PS, Fontana V, Palei ACT, Sertorio JTC, Biagi C, Tanus-Santos JE. Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers [Internet]. European Journal of Clinical Pharmacology. 2011 ; 67( 4): 365-370.[citado 2026 mar. 14 ] Available from: https://doi.org/10.1007/s00228-011-1003-x - Xanthine oxidoreductase contributes to vasodillation and antihypertensive effects of sodium nitrite in renovascular hypertension
- L-arginina atenua a hipertensão pulmonar decorrente de embolia pulmonar aguda
- Elevated plasma hemoglobin levels increase nitric oxide consumption in experimental and clinical acute pulmonary thromboembolism
- eNOS polymorphism associated with metabolic syndrome in children and adolescents
- Vascular damage in resistant hypertension: TNF-alpha inhibition effects on endothelial cells
- Adiponectin -11377C/G and +276G/T polymorphisms affect adiponectin levels but not modify responsiveness to therapy in resistant hypertension
- Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin
- Estresse oxidativo prejudica o efeito vasodilatador do nitrito de sódio mediado pela xantina oxidoredutase na hipertensão renovascular
- A metaloproteinase da matriz-2 (MMP-2) contribui para a disfunção vascular da hipertensão renovascular
- Atorvastatina reduz a hipertensão arterial pulmonar causada por embolia pulmonar aguda (EPA) em ratos
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
